CellWell record HH-132917
Positive prognostic implications of SPHK1 expression in patients with papillary thyroid carcinoma undergoing radioactive iodine therapy
Kyung Won Park; Ja Seong Bae; Dong-Jun Lim; Chan Kwon Jung
2026
In plain language
In 471 papillary thyroid carcinoma patients, SPHK1 protein positivity was associated with the BRAF V600E mutation and predicted better recurrence-free survival, especially in patients under 55 treated with radioactive iodine therapy.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-132917
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.